Navigation Links
Teenagers and young adults with cancer can face long delays before finally being diagnosed
Date:6/8/2008

g pain, a lump or swelling, weight loss or tiredness. Almost all of them had two or three of these symptoms. Of the one in five who delayed seeking help, most (63%) said that either they or their parents had felt that the symptoms weren't serious; a small number had been too embarrassed or scared to seek help.

"If young people are reporting to their GP with what are recognised as being pretty classic cancer symptoms, cancer should be considered the first possibility and not the last resort," said Ms Smith. "However, following the first onset of symptoms many young people reported numerous visits to their GP before being referred to a specialist and many waited several months for this referral to take place. Our findings do show that age is a factor in the number of GP visits, with the older age group reporting more visits before being referred.

"The minority of patients who did delay seeking help sometimes waited for several months. Of that small group, about 60% had Hodgkin lymphoma, which normally presents slowly with increasing swelling most commonly in the neck, but it can be elsewhere in the body."

Leukaemia was the quickest of the cancers to be referred to a specialist, probably because it usually presents with a number of acute signs and symptoms. "However, it is of great concern that some of the commonest cancers at this age Hodgkin lymphoma, brain and bone cancers were the slowest to be referred to a specialist. For example, 54% of patients with Hodgkin lymphoma, 59% with brain tumours and 46% with bone tumours visited their GP four or more times with symptoms before referral," said Ms Smith.

Prof Eden said: "A small number of patients may delay in seeking help and we can improve education about health and the meaning of symptoms for the public, but the biggest challenge seems to be to overcome delays by professionals. We need to assist professionals in: recognising signs and symptoms as being potentially serious; refe
'/>"/>

Contact: Emma Mason
wordmason@mac.com
44-077-112-96986
Teenage Cancer Trust
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Teenagers attending college less likely to engage in risky sexual behavior
2. Nearly 1 in 5 teenagers admit eating problems, but anxiety is a bigger problem than appearance
3. Blind Tibetan Teenagers Featured in Award-Winning Film, Blindsight, Unite with Students from Junior Blind of America to Share Life Experiences
4. Young patient waited ten months before being diagnosed with cancer
5. Nonprofit Organization Dedicated to Helping Young Adult Cancer Survivors Raises $4500 for Leanna Elizalde
6. Initiating drinking at younger age heightens womens risk for alcohol dependence
7. AstraZeneca submits an sNDA for Symbicort for treatment of asthma in children as young as 6
8. Study finds link between amphetamine abuse and heart attacks in young adults
9. Phillys Top Docs Organize to Help Prevent Young Athlete Deaths in Philadelphia
10. Young Hodgkin Survivors Face Later Risk of Second Cancers
11. Study examines cold medication use in young children
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 2Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 3Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 4Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 5Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 6Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 7Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 8Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 9Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 2Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 3Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 4Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 5Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 6Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 7Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 8Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 9More than half of Texas physicians do not always recommend HPV vaccine to girls 9494 1More than half of Texas physicians do not always recommend HPV vaccine to girls 9494 2New clues about a hydrogen fuel catalyst 13404 1New clues about a hydrogen fuel catalyst 13404 2New clues about a hydrogen fuel catalyst 13404 3ULURU Inc Announces Conference Call to Discuss Financial Results for the Second Quarter Ended June 30 2009 and to Provide a Business Update 53793 1ULURU Inc Announces Conference Call to Discuss Financial Results for the Second Quarter Ended June 30 2009 and to Provide a Business Update 53793 2
Other Medicine Technology:New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 2New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 3New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 4New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 5New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 6New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 7New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 8New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 9New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 10New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 11New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 12New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 13New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 14QRxPharma Releases Successful Phase 3 Study Results for 'Dual Opioid' Pain Therapy 2QRxPharma Releases Successful Phase 3 Study Results for 'Dual Opioid' Pain Therapy 3